Home/Filings/4/0001104659-24-010110
4//SEC Filing

Morris Richard Steven 4

Accession 0001104659-24-010110

CIK 0001485003other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:53 PM ET

Size

5.7 KB

Accession

0001104659-24-010110

Insider Transaction Report

Form 4
Period: 2024-01-31
Morris Richard Steven
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-31+170,500170,500 total
    Exercise: $2.10Exp: 2034-01-31Common Stock (170,500 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.

Issuer

Carisma Therapeutics Inc.

CIK 0001485003

Entity typeother

Related Parties

1
  • filerCIK 0001432303

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:53 PM ET
Size
5.7 KB